Food and Drug Administration

Arthritis Advisory Committee

June 24, 2003

Briefing Information

Enbrel® (etanercept)


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Document Presented by Amgen, Inc. (HTM) (PDF) (Word)

Briefing Document Presented by FDA (HTM) (PDF) (Word)